FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

830911000001106: Zantac 300mg effervescent tablets (GlaxoSmithKline) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
16799301000001112 Zantac 300mg effervescent tablets (GlaxoSmithKline) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
58223501000001119 Zantac 300mg effervescent tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has excipient Aspartame false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has active ingredient Ranitidine false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Is a Zantac true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has dispensed dose form Effervescent tablet false Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) Has dispensed dose form Conventional release effervescent oral tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Is pack of False Zantac 300mg effervescent tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Zantac 300mg effervescent tablets (GlaxoSmithKline) 30 tablet 2 x 15 tablets Has AMP True Zantac 300mg effervescent tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start